Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry

24 April 2021 (19:20 - 20:20)
Organised by:
Congress Presentation Part of: News from ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2021

ESC 365 is supported by

ESC 365 is supported by